Canine cancer vaccine tale sparks a new AI-backed biotech startup

The Verge reports that Paul Conyngham, who popularized an AI-assisted dog cancer vaccine, has launched Gamgee to commercialize personalized mRNA cancer vaccines for dogs and eventually humans. Backed by Y Combinator and collaborating with Australian universities, Gamgee aims to scale such therapies, but scientists say Rosie’s story is not clearly attributable to AI and the company’s ambitious timelines and costs remain unproven.